ASSESSING THE IMPLEMENTABILITY OF REGULATORY AGENCIES' GUIDANCE ON DIVERSITY IN CLINICAL TRIALS

被引：0
|
作者：
Metcalfe, R. [1 ]
Reshef, S. [2 ]
Park, J. [1 ]
机构：
[1] Core Clin Sci, Vancouver, BC, Canada
[2] Teva Branded Pharmaceut Prod R&D Inc, Epidemiol & Global Hlth Econ & Outcomes Res, Parsippany, NJ USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HPR87
引用
收藏
页码：S209 / S209
页数：1
相关论文
共 50 条
  • [31] The need for greater involvement of regulatory agencies in assessing adverse drug reactions
    Sniderman, AD
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2000, 162 (02) : 209 - 210
  • [32] ASSESSING CLINICAL-TRIALS
    SPODICK, DH
    BRITISH MEDICAL JOURNAL, 1981, 283 (6283): : 64 - 65
  • [33] Assessing the validity of clinical trials
    Akobeng, Anthony K.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2008, 47 (03): : 277 - 282
  • [34] Two Federal Agencies Tighten Rules for Clinical Trials
    Fillon, Mike
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2016, 108 (12):
  • [35] Ensuring diversity in clinical trials
    Adams-Campbell, Lucile
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2023, 32 (12)
  • [36] More Diversity in Clinical Trials
    Rubin, Rita
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (19): : 1860 - 1860
  • [37] The Importance of Diversity in Clinical Trials
    Johnson-Williams, Bernadette
    Jean, Daphney
    Liu, Qi
    Ramamoorthy, Anuradha
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 (03) : 486 - 488
  • [38] Guidance on interim analysis methods in clinical trials
    Ciolino, Jody D.
    Kaizer, Alexander M.
    Bonner, Lauren Balmert
    JOURNAL OF CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 7 (01)
  • [39] REGULATORY AUTHORIZATION OF CLINICAL-TRIALS
    SNELL, ES
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 15 (06) : 625 - 627
  • [40] Regulatory issues for clinical trials in humans
    Collins, JF
    Sather, MR
    EPIDEMIOLOGIC REVIEWS, 2002, 24 (01) : 59 - 66
12345